Vlado Perkovic

Vlado Perkovic is the Provost at UNSW Sydney, and previously the Dean of the Faculty of Medicine and Health at UNSW, a Professorial Fellow at The George Institute, Australia, and was a Staff Specialist in Nephrology at the Royal North Shore Hospital. His research focus is clinical trials, and he is a globally recognised expert in kidney trials, trial methodology and operations. He previously established the CRO George Clinical as a subsidiary of the George Institute (now sold), was Executive Director of that organisation for several years, and continues to serve on the Board. He has led several major international clinical trials that have changed treatment paradigms, including trials that have underpinned the approval of 3 new drugs, all of which were first in class in kidney disease. He currently leads the Steering Committees of several ongoing trials and has recently established the first global patient registry and platform trial in chronic kidney disease. He has been involved in developing Australian and global guidelines in kidney disease, cardiovascular risk assessment and blood pressure management.

He was previously foundation Chair of the International Society of Nephrology Advancing Clinical Trials (ISN ACT) initiative, the Chair of the Scientific Committee of the Australasian Kidney Trials network, President of the Australian Association of Medical Research Institutes, and a Board Director for the Australian Clinical Trial Alliance. He continues to serve on the Boards of several Medical Research Institutes, as well as George Clinical and St. Vincents Health Australia

Vlado holds a Doctor of Philosophy from the University of Melbourne and completed his

undergraduate training at The Royal Melbourne Hospital. He is a Fellow of the Royal Australasian College of Physicians, of the Australian Academy of Health and Medical Sciences and of the American Society of Nephrology.